MacroGenics Q2 EPS and revenue miss estimates

Seeking Alpha··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

MacroGenics reported second-quarter 2026 financial results that missed analyst expectations. GAAP EPS came in at a loss of $1.10 per share, missing estimates by $1.02. Revenue was $32.83 million, up 377.9% year-over-year, but fell short of expectations by $26.31 million.

Impact on assets 1

Biotech & Genomic Medicine▼ · 1 stocks
© 2026 MarketIVNews